Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classifica tra le azioni #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Prezzo delle azioni
$62.83
Capitalizzazione di mercato
$93.23B
Variazione (1 giorno)
-9.17%
Variazione (1 anno)
-31.36%
Paese
US
Scambia Boston Scientific Corporation (BSX)

Categoria

Ricavi di Boston Scientific Corporation (BSX)
Ricavi nel Dec 2025 TTM: $20.08B
Secondo gli ultimi rapporti finanziari di Boston Scientific Corporation, i ricavi attuali dell'azienda (TTM) sono pari a $20.08B. Nel 2024, l'azienda ha registrato ricavi di $16.75B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $14.24B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Boston Scientific Corporation da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $20.08B 0.00%
2025 $20.07B 19.87%
2024 $16.75B 17.61%
2023 $14.24B 12.29%
2022 $12.68B 6.68%
2021 $11.89B 19.92%
2020 $9.91B -7.66%
2019 $10.74B 9.28%
2018 $9.82B 8.57%
2017 $9.05B 7.89%
2016 $8.39B 12.16%
2015 $7.48B 1.31%
2014 $7.38B 3.32%
2013 $7.14B -1.46%
2012 $7.25B -4.89%
2011 $7.62B -2.36%
2010 $7.81B -4.67%
2009 $8.19B 1.71%
2008 $8.05B -3.67%
2007 $8.36B 6.85%
2006 $7.82B 24.48%
2005 $6.28B 11.72%
2004 $5.62B 61.80%
2003 $3.48B 19.08%
2002 $2.92B 9.20%
2001 $2.67B 0.34%
2000 $2.66B 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$44.33B 120.81%
US
$25.12B 25.11%
US
$35.49B 76.80%
IE
$35.48B 76.76%
IE
$25.70B 28.01%
DE